James Crowe
Faculty Member
Last active: 3/31/2019

  1. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE (2013) MBio 4(6): e00873-13
    › Primary publication · 24255124 (PubMed) · PMC3870244 (PubMed Central)
  2. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency. Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE (2013) J Immunol 190(7): 3732-9
    › Primary publication · 23455501 (PubMed) · PMC3608519 (PubMed Central)
  3. Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. Zeitlin L, Bohorov O, Bohorova N, Hiatt A, Kim DH, Pauly MH, Velasco J, Whaley KJ, Barnard DL, Bates JT, Crowe JE, Piedra PA, Gilbert BE (2013) MAbs 5(2): 263-9
    › Primary publication · 23396091 (PubMed) · PMC3893236 (PubMed Central)
  4. Molecular mechanisms driving respiratory syncytial virus assembly. Shaikh FY, Crowe JE (2013) Future Microbiol 8(1): 123-31
    › Primary publication · 23252497 (PubMed) · PMC3577052 (PubMed Central)
  5. Impact of new sequencing technologies on studies of the human B cell repertoire. Finn JA, Crowe JE (2013) Curr Opin Immunol 25(5): 613-8
    › Primary publication · 24161653 (PubMed) · PMC3882336 (PubMed Central)
  6. Immunology. Crowdsourcing immunity. Crowe JE (2013) Science 340(6133): 692-3
    › Primary publication · 23661747 (PubMed)
  7. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. Aiyegbo MS, Sapparapu G, Spiller BW, Eli IM, Williams DR, Kim R, Lee DE, Liu T, Li S, Woods VL, Nannemann DP, Meiler J, Stewart PL, Crowe JE (2013) PLoS One 8(5): e61101
    › Primary publication · 23671563 (PubMed) · PMC3650007 (PubMed Central)
  8. Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics. Smith SA, de Alwis R, Kose N, Durbin AP, Whitehead SS, de Silva AM, Crowe JE (2013) J Infect Dis 207(12): 1898-908
    › Primary publication · 23526830 (PubMed) · PMC3654755 (PubMed Central)
  9. Human germline antibody gene segments encode polyspecific antibodies. Willis JR, Briney BS, DeLuca SL, Crowe JE, Meiler J (2013) PLoS Comput Biol 9(4): e1003045
    › Primary publication · 23637590 (PubMed) · PMC3636087 (PubMed Central)
  10. Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses. Thornburg NJ, Nannemann DP, Blum DL, Belser JA, Tumpey TM, Deshpande S, Fritz GA, Sapparapu G, Krause JC, Lee JH, Ward AB, Lee DE, Li S, Winarski KL, Spiller BW, Meiler J, Crowe JE (2013) J Clin Invest 123(10): 4405-9
    › Primary publication · 23999429 (PubMed) · PMC3784541 (PubMed Central)